SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3

Prostate cancer (PCa) is one of the most incident cancers worldwide but clinical and pathological parameters have limited ability to discriminate between clinically significant and indolent PCa. Altered expression of histone methyltransferases and histone methylation patterns are involved in prostat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Filipa Quintela, Costa-Pinheiro, Pedro, Almeida-Rios, Diogo, Graça, Inês, Monteiro-Reis, Sara, Simões-Sousa, Susana, Carneiro, Isa, Sousa, Elsa Joana, Godinho, Maria Inês, Baltazar, Fátima, Henrique, Rui, Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537039/
https://www.ncbi.nlm.nih.gov/pubmed/25980436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537039/
https://www.ncbi.nlm.nih.gov/pubmed/25980436

Ejemplares similares